Institutional investors control 12.81% of the outstanding shares in ACUR. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Generic industry. Additionally, during the quarter ended September 2016, these large investors purchased a net $112.7 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ALLIANCEBERNSTEIN LP Bought 103.4 Thousand shares of Acura Pharmaceuticals Inc